Viewing Study NCT03826992


Ignite Creation Date: 2025-12-24 @ 3:40 PM
Ignite Modification Date: 2025-12-25 @ 1:50 PM
Study NCT ID: NCT03826992
Status: RECRUITING
Last Update Posted: 2025-05-14
First Post: 2019-01-09
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Venetoclax Combined With Vyxeos (CPX-351) for Participants With Relapsed or Refractory Acute Leukemia
Sponsor: Children's Hospital Medical Center, Cincinnati
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module